3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
48
Other solid neoplasm
11
Gynecologic
10
Genitourinary
10
Gastrointestinal
10
Breast
10
Dermatologic
9
Sarcoma
7
Other hematologic neoplasm
5
Head & Neck
5
Endocrine
5
Myeloid
4
Lymphoid
4
Plasma cell
3
CNS
3
Classical hematology
2
NET
1
Conditions
Neuroendocrine Tumors
208
Carcinoid Tumor
26
Neoplasms
22
Pancreatic Neoplasms
16
Gastro-enteropancreatic neuroendocrine tumor
14
Carcinoma, Neuroendocrine
11
Carcinoma
11
Adenoma, Islet Cell
11
Neoplasm Metastasis
10
Colorectal Neoplasms
9
Lung Neoplasms
8
Serotonin Syndrome
7
Prostatic Neoplasms
7
Adenocarcinoma
7
Pheochromocytoma
6
Gastrointestinal Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Somatostatinoma
5
Neuroblastoma
5
Melanoma
5
Gastroenteropancreatic Neuroendocrine Tumors
5
Cholangiocarcinoma
5
Carcinoma, Renal Cell
5
Vipoma
4
Sarcoma
4
Rectal Neoplasms
4
Paraganglioma
4
Interventions
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thymoma
×
NET
×
Clear all
NCT04375267
2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1
Completed
18 enrolled